No Data
FTC to Sue Pharmacy Benefit Managers Over Insulin Prices
By Liz Essley Whyte and Anna Wilde Mathews The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating prices for drugs including
CVS Health's Options Frenzy: What You Need to Know
Deep-pocketed investors have adopted a bearish approach towards CVS Health (NYSE:CVS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled
Dividend Roundup: Procter & Gamble, Costco, CVS Health, Colgate-Palmolive, and More
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical
CVS Health Corporation's (NYSE:CVS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know